|
Report Date : |
25.01.2013 |
IDENTIFICATION DETAILS
|
Name : |
SANDOZ GMBH |
|
|
|
|
Registered Office : |
Biochemiestraße 10, A-6250 Kundl |
|
|
|
|
Country : |
Austria |
|
|
|
|
Financials (as on) : |
31.12.2011 |
|
|
|
|
Date of Incorporation : |
18.11.1965 |
|
|
|
|
Legal Form : |
limited liability company |
|
|
|
|
Line of Business : |
Manufacture of pharmaceutical preparations |
|
|
|
|
No. of Employees : |
Not Available |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No complaints |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 30th, 2012
|
Country Name |
Previous Rating (31.03.2012) |
Current Rating (30.06.2012) |
|
Austria |
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
austria - ECONOMIC OVERVIEW
Austria, with its well-developed market economy, skilled labor force,
and high standard of living, is closely tied to other EU economies, especially
Germany's. Its economy features a large service sector, a sound industrial
sector, and a small, but highly developed agricultural sector. Following
several years of solid foreign demand for Austrian exports and record
employment growth, the international financial crisis of 2008 and subsequent
global economic downturn led to a sharp but brief recession. Austrian GDP
contracted 3.9% in 2009 but saw positive growth of about 2% in 2010 and 3% in
2011. Unemployment did not rise as steeply in Austria as elsewhere in Europe, partly
because the government subsidized reduced working hour schemes to allow
companies to retain employees. Stabilization measures, stimulus spending, and
an income tax reform pushed the budget deficit to 4.7% in 2010 and 3.6% in
2011, from only about 1.3% in 2008. The international financial crisis of 2008
caused difficulties for Austria''s largest banks whose extensive operations in
central, eastern, and southeastern Europe faced large losses. The government
provided bank support - including in some instances, nationalization - to
support aggregate demand and stabilize the banking system. Austria''s fiscal
position compares favorably with other euro-zone countries, but it faces
considerable external risks, such as Austrian banks'' continued high exposure to
central and eastern Europe as well as political and economic uncertainties
caused by the European sovereign debt crisis. In 2011 the government attempted
to pass a constitutional amendment limiting public debt to 60% of GDP by 2020,
but it was unable to obtain sufficient support in parliament and instead passed
the measure as a simple law. In March 2012, the Austrian parliament approved an
austerity budget that will bring public finances into balance by 2016.
|
Source : CIA |
|
Last up-date: |
2013-01-23 |
|
Company name: |
Sandoz GmbH |
|
Status: |
active company |
|
Locations: |
Biochemiestraße 10,
A-6250 Kundl |
|
Phone: |
0043 (5338) 200 |
|
Fax: |
0043 (5338) 200 - 415 |
|
E-mail: |
|
|
Internet: |
|
|
Internet: |
|
|
Activities: |
Önace 21200 100% Manufacture of
pharmaceutical preparations |
|
|
|
|
General Assessment: |
Model: CompanyScore |
|
Probability of Default (Basel
II): |
0,10% Very low risk |
|
Recommendation: |
In respect to solvency
reasons, there is nothing to say against an establishment of a business
relationship. |
|
|
|
|
Detail Assessment: |
Payments are sometimes made
using cash discounts or according to conditions. |
|
|
Financial situation is good. |
|
Date
of collection order |
Amount presently due |
Amount presently paid |
Collection status quo |
since |
|
2012-11-08 |
EUR 0,00 |
EUR 348,96 |
payment due to KSV
intervention |
2012-12-04 |
|
Sums |
EUR 0,00 |
EUR 348,96 |
|
|
|
Year of incorporation: |
1965 |
|
||||
|
Type of company: |
Manufacturing |
|
||||
|
Legal form: |
limited liability company
since 1965-11-18 |
|
||||
|
companies' house number: |
FN 50587 v Innsbruck
1965-11-26 |
|
||||
|
Activities: |
|
|
||||
|
ARA-number: |
3462 |
|
||||
|
VAT number: |
ATU 32425809 |
|
||||
|
number - Austrian National
Bank: |
4812 |
|
||||
|
|
||||||
|
Export |
Country |
|
|
|
||
|
Export |
world-wide |
|
2013 |
|
||
|
total turnover (total sales) |
2012 |
EUR 1.480.000.000,00 |
(estimated) |
|
total turnover (total sales) |
2011 |
EUR 1.480.566.195,12 |
(exact) |
|
total turnover (total sales) |
2010 |
EUR 1.428.954.760,56 |
(exact) |
|
total turnover (total sales) |
2009 |
EUR 1.315.733.905,62 |
(exact) |
|
total turnover (total sales) |
2008 |
EUR 1.263.133.197,81 |
(exact) |
|
total employees |
2013 |
3117 |
(approx.) |
|
total investments |
2011 |
EUR 57.242.907,14 |
(exact) |
|
firm
(style): |
|
63 Sandoz GmbH |
|
legal
form: |
|
1 Gesellschaft mit beschränkter Haftung |
|
registered
office: |
|
1 politischer Gemeinde Kundl |
|
business
adress: |
|
15 Biochemiestraße 10 |
|
capital: |
|
52 EUR 32.703.000 |
|
reference
date annual accounts: |
|
1 31. Dezember |
|
annual
accounts: |
|
126 zum 31.12.2011 eingereicht am
03.09.2012 |
|
power
of representation: |
|
1 Die Gesellschaft wird, wenn mehrere
Geschäftsführer |
|
other provisions: |
|
8 Der Aufsichtsrat besteht aus sechs
Mitgliedern. |
|
proxy: |
|
CT Sibylla Härtel, geb. 21.10.1962 |
|
supervisory
board: |
|
CX Helmut Pancheri, geb. 05.07.1961 |
|
managing
director: |
|
BD Mag. Hubert Hirzinger, geb. 10.05.1957 |
|
shareholder: |
|
CM Novartis Holding AG |
|
general table: |
|
Landesgericht Innsbruck |
|
Registration number of real estate 100 Cadastral register 83108 Kundl T Number and date of entry 2460/2011 Status of 2012-06-12 |
|
Part A - type of
real estate : |
|
GST-NR G BA (NUTZUNG) FLÄCHE GST-ADRESSE |
|
Part
B - ownership details : |
|
1 ANTEIL: 1/1 |
|
Part
C - registered charges : |
|
3 a 1589/1993 |
Private data:
|
Surname |
Date of birth |
Address |
Executive positions |
Further executive positions
(as registered in the companies' house) |
|
Dr. Peter Gasteiger |
1972-06-30 |
6250 Kundl Biochemiestraße 10 |
manager, head of personnel |
0 |
|
Mag. Hubert Hirzinger |
1957-05-10 |
6250 Kundl Biochemiestraße 10
(p/A Sandoz GmbH) |
manager |
4 |
|
Dipl-Ing. Ernst
Meijinders |
1956-12-14 |
6250 Kundl Biochemiestraße 10 |
manager |
0 |
|
Dr. Günter Stempfer |
1965-12-09 |
6250 Kundl Biochemiestraße 10 |
manager |
0 |
|
Mag. Hans Peter Amon |
1975-01-19 |
1020 Wien Stella Klein Löwweg
17 |
joint signing clerk, head of accounting |
6 |
|
Dkfm. Michael Friedhofen |
1967-08-27 |
1235 Wien Carlbergergasse 44 |
joint signing clerk |
1 |
|
Sibylla Härtel |
1962-10-21 |
6250 Kundl Biochemiestraße
10(c/o) |
joint signing clerk |
0 |
|
Michael Kocher |
1967-04-12 |
6250 Kundl c/o Sandoz GmbH
Biochemiestraß 10 |
joint signing clerk |
0 |
|
Dr. Nikolaus Kofler |
1968-12-05 |
6250 Kundl c/o Sandoz GmbH
Biochemiestraß 10 |
joint signing clerk |
0 |
|
Mag. Ingrid
Schwarzenberger |
1958-03-20 |
6250 Kundl Biochemiestraße
10(c/o) |
joint signing clerk |
0 |
|
Dr. Friedrich Sernetz |
1967-03-05 |
1020 Wien Stella Klein Löwweg
17 |
joint signing clerk |
2 |
|
Mag. Christian Seiwald |
1952-10-02 |
6250 Kundl Biochemiestraße
10(c/o) |
chairman of the supervisory
board |
0 |
|
Peter Goldschmidt |
1964-10-19 |
83607 Holzkirchen c/o Sandoz
International GmbH 25 |
deputy chairman of the
supervisory board |
0 |
|
Dr. Josef Egerbacher |
1958-11-20 |
6250 Kundl Biochemiestraße
10(c/o) |
member of the supervisory
board |
0 |
|
Hans Helmut Michael Fabry |
1956-09-18 |
6250 Kundl Biochemiestraße
10(c/o) |
member of the supervisory
board |
0 |
|
Barbara Nerad |
1962-12-30 |
6250 Kundl Biochemiestraße 10 |
member of the supervisory
board |
0 |
|
Helmut Pancheri |
1961-07-05 |
6250 Kundl Biochemiestraße
10(c/o) |
member of the supervisory
board |
0 |
|
Mag. Max Leitinger |
|
6250 Kundl Biochemiestraße
10(c/o) |
head of EDP |
0 |
|
Josef Postl |
|
6250 Kundl Biochemiestraße 10(c/o) |
technical director |
0 |
|
|
2011-12-31 |
|
|
|
|
|
Franchises, patents, licences,
trademarks and similar rights and advantages |
10.064.985,08 |
|
|
|
|
|
Sum intangible assets |
10.064.985,08 |
|
|
|
|
|
|
|||||
|
Land and leasehold rights with
buildings thereon including building on land owned by third parties |
228.193.055,85 |
|
|
|
|
|
Other operating and business
equipment |
13.650.996,87 |
|
|
|
|
|
Technical plants and machines |
134.107.511,98 |
|
|
|
|
|
Advanced payments and
constructions in progress |
15.910.440,45 |
|
|
|
|
|
Sum tangible assets |
391.862.005,15 |
|
|
|
|
|
|
|||||
|
Shares on related firms |
35.906.602,18 |
|
|
|
|
|
Other shareholdings |
1.751.901,77 |
|
|
|
|
|
Other financial assets, values
and securities of fixed assets |
16.543.415,90 |
|
|
|
|
|
Sum financial assets |
54.201.919,85 |
|
|
|
|
|
|
|||||
|
Sum fixed assets |
456.128.910,08 |
|
|
|
|
|
|
|||||
|
Raw-, auxiliary materials and
supplies |
45.677.551,03 |
|
|
|
|
|
Unfinished products |
128.720.025,06 |
|
|
|
|
|
Finished products |
46.273.331,82 |
|
|
|
|
|
Sum stock |
220.670.907,91 |
|
|
|
|
|
|
|||||
|
Claims from delivered goods
and performed services |
125.271.523,56 |
|
|
|
|
|
Claims against companies with
shareholding relationship |
1.592.408,34 |
|
|
|
|
|
Claims against related firmes
Claims against companies with shareholding relationship |
286.035.355,40 |
|
|
|
|
|
Other claims and assets |
66.769.961,81 |
|
|
|
|
|
Sum claims |
479.669.249,11 |
|
|
|
|
|
|
|||||
|
Cash on hand, cheques and bank
deposits |
1.708.659,08 |
|
|
|
|
|
Sum cash and bank |
1.708.659,08 |
|
|
|
|
|
|
|||||
|
Sum current assets |
702.048.816,10 |
|
|
|
|
|
|
|||||
|
Deferred charges |
895.425,87 |
|
|
|
|
|
Sum deferred charges |
895.425,87 |
|
|
|
|
|
Assets |
1.159.073.152,05 |
|
|
|
|
|
|
|||||
|
Subscribed/declared capital |
32.703.000,00 |
|
|
|
|
|
Legal reserves |
3.270.300,00 |
|
|
|
|
|
Free reserves |
59.656.425,77 |
|
|
|
|
|
Balance sheet profit/balance
sheet loss |
0,00 |
|
|
|
|
|
Sum equity capital |
95.629.725,77 |
|
|
|
|
|
|
|||||
|
Other reserves before taxes |
25.501.372,79 |
|
|
|
|
|
Sum reserves before taxes |
25.501.372,79 |
|
|
|
|
|
|
|||||
|
Investment contributions |
835.567,55 |
|
|
|
|
|
Sum floor capital |
835.567,55 |
|
|
|
|
|
|
|||||
|
Reservesfor severance pays |
35.647.009,00 |
|
|
|
|
|
Reserves for pensions |
47.800.759,00 |
|
|
|
|
|
Tax reserves |
10.055.108,79 |
|
|
|
|
|
Other reserves |
65.768.259,79 |
|
|
|
|
|
Sum reserves |
159.271.136,58 |
|
|
|
|
|
|
|||||
|
Liabilities against credit
institutes |
123.970.782,44 |
|
|
|
|
|
Received advanced payments for
orders |
3.666.719,51 |
|
|
|
|
|
Liabilities from delivered
goods and performed services from the acceptance of drafts and emission of
promissory notes |
91.922.789,79 |
|
|
|
|
|
Liabilities against related
firms |
639.642.691,05 |
|
|
|
|
|
Liabilities against firm with
shareholding relationship |
4.205.909,83 |
|
|
|
|
|
Other liabilities |
11.087.726,12 |
|
|
|
|
|
Other loans |
2.843.800,00 |
|
|
|
|
|
Sum liabilities |
877.340.418,74 |
|
|
|
|
|
|
|||||
|
Deferred income |
494.930,62 |
|
|
|
|
|
Sum deferred income |
494.930,62 |
|
|
|
|
|
Liabilities |
1.159.073.152,05 |
|
|
|
|
|
|
|||||
|
Contingent liabilities |
6.000.000,00 |
|
|
|
|
|
Balance sheet sum |
1.159.073.152,05 |
|
|
|
|
P / L
Account (absolute) all amounts in EUR
|
|
2011-12-31 |
|
|
|
|
|
Gross sales |
1.480.566.195,12 |
|
|
|
|
|
Increase or decrease in finished
and unfinished goods and in service claims |
-5.948.062,01 |
|
|
|
|
|
Other manufacturing costs
capitalized |
3.656.823,95 |
|
|
|
|
|
Sum turnover or sum gross
profit |
1.478.274.957,06 |
|
|
|
|
|
|
|||||
|
Profits from retirement of fixed
assets, except financial assets |
38.436,67 |
|
|
|
|
|
Income from dissolution of
reserves |
432.524,65 |
|
|
|
|
|
Other operating profits |
19.083.806,60 |
|
|
|
|
|
Other operating profits
totally |
19.554.767,92 |
|
|
|
|
|
|
|||||
|
Costs for obtained services |
-32.813.160,68 |
|
|
|
|
|
Special account material costs |
-849.578.777,78 |
|
|
|
|
|
Costs for obtained services
totally |
-882.391.938,46 |
|
|
|
|
|
|
|||||
|
Wages |
-24.203.737,38 |
|
|
|
|
|
Salaries |
-125.500.302,99 |
|
|
|
|
|
Costs for severance pays |
-1.891.479,08 |
|
|
|
|
|
Costs for old age pension |
-1.815.900,88 |
|
|
|
|
|
Legal fringe benefits and
other payments depending on salaries |
-40.098.996,07 |
|
|
|
|
|
Other social fringe benefits |
-4.851.881,29 |
|
|
|
|
|
Personnel expenses totally |
-198.362.297,69 |
|
|
|
|
|
|
|||||
|
Depreciation of intangible
assets, tangible assets,activated expenses for the set up and expansion of
business operation |
-64.570.320,04 |
|
|
|
|
|
Depreciation tangible assets /
intangible assets totally |
-64.570.320,04 |
|
|
|
|
|
|
|||||
|
Different operating costs |
-239.595.168,87 |
|
|
|
|
|
Other taxes |
-2.061.461,09 |
|
|
|
|
|
Other operating costs totally |
-241.656.629,96 |
|
|
|
|
|
|
|||||
|
Operating result totally |
110.848.538,83 |
|
|
|
|
|
|
|||||
|
Profits from shareholdings |
19.043.754,18 |
|
|
|
|
|
Income from other securities
and loans of financial assets |
585.635,69 |
|
|
|
|
|
Interest income, securties
income and similar income |
410.116,20 |
|
|
|
|
|
Interest and similar
disbursements |
-10.317.942,11 |
|
|
|
|
|
Financial expenses |
-664.878,62 |
|
|
|
|
|
Financial profits totally |
9.056.685,34 |
|
|
|
|
|
|
|||||
|
Results from usual business
activity totally |
119.905.224,17 |
|
|
|
|
|
|
|||||
|
Taxes on income and profits |
-13.021.962,03 |
|
|
|
|
|
Taxes on income and profits
totally |
-13.021.962,03 |
|
|
|
|
|
Annual surplus/annual deficit
totally |
106.883.262,14 |
|
|
|
|
|
|
|||||
|
Dissolution reserves before
taxes |
784.409,85 |
|
|
|
|
|
Dissolution capital reserves |
500.000,00 |
|
|
|
|
|
Reserves movements totally |
1.284.409,85 |
|
|
|
|
|
Annual profit/annual loss
totally |
108.167.671,99 |
|
|
|
|
|
|
|||||
|
Transfer of
profit/overcounting of losses from ontract of profit transfer |
-108.167.671,99 |
|
|
|
|
|
Transfer of profits totally |
-108.167.671,99 |
|
|
|
|
|
B/S profit/ B/S loss from
profit and loss account |
0,00 |
|
|
|
|
Key
ratios
|
|
2011 |
|
|
|
|
|
|
Cash flow II |
171.453.582,18 |
|
|
|
|
|
|
Debt amortisation period |
6,01 |
|
|
|
|
|
|
Bank indebtedness |
10,94 |
|
|
|
|
|
|
Equity capital share |
10,55 |
|
|
|
|
|
|
Social capital share |
7,19 |
|
|
|
|
|
|
Fixed assets coverage |
45,03 |
|
|
|
|
|
|
Net profit ratio |
8,11 |
|
|
|
|
|
|
Capital turnover |
1,27 |
|
|
|
|
|
|
Return on investment |
11,23 |
|
|
|
|
|
|
Cash flow in % of operating
performance |
11,59 |
|
|
|
|
|
|
Cash flow I |
184.475.544,21 |
|
|
|
|
|
|
Gross productivity |
7,45 |
|
|
|
|
|
|
Net productivity |
3,00 |
|
|
|
|
|
|
Operating performance |
1.478.274.957,06 |
|
|
|
|
|
|
Inventories in % of operating
performance |
14,92 |
|
|
|
|
|
|
Gross profit |
595.883.018,60 |
|
|
|
|
|
Locations
|
Type |
Locations |
Description |
|
|
|
E-mail |
|
operational |
Dr. Hans Bachmannstraße 7,
A-6250 Kundl, (umben.auf Biochemiestraße 10) |
registered headquarters |
|
|
|
|
|
operational |
Schaftenau
Biochemiestraße 10, A-6330 Kufstein |
factory, owned property |
|
|
|
|
|
operational |
Biochemiestraße 10,
A-6250 Kundl |
registered office |
|
|
|
|
|
operational |
Biochemiestraße 10,
A-6250 Kundl |
registered headquarters, owned
property |
|
|
|
kundl.austria@sandoz.com |
|
operational |
Brunnerstraße 59, A-1230
Wien |
branch office, rented premises |
|
|
|
|
|
former |
Wagramerstraße 19,
A-1220 Wien |
branch office |
|
|
|
|
related companies:
|
Company name |
Postal code |
Stake in % |
|
Companies House |
|
Shares in this company are
held by: |
||||
|
Novartis Austria GmbH |
Stella Klein Löwweg 17,
A-1020 Wien |
99.99 % 2006-07-27 |
|
FN 274620 d |
|
Novartis Holding AG |
Lichtstraße 35, CH-4056
Basel |
0.01 % 1997-02-22 |
|
|
|
|
||||
|
This company holds 100% of the
shares in: |
||||
|
HEXAL PHARMA GmbH |
Stella Klein Löw Weg 17,
A-1020 Wien |
100 % 2005-12-17 |
|
FN 44896 z |
|
Novartis Institutes for
Biomedical Research GmbH |
Biochemiestraße 10,
A-6250 Kundl |
100 % 1993-08-13 |
|
FN 43251 f |
|
Novartis Animal Health GmbH |
Biochemiestraße 10,
A-6250 Kundl |
100 % 1996-12-03 |
|
FN 152616 k |
|
|
||||
|
This company holds 50% to 99%
of the shares in: |
||||
|
Biozym GmbH |
Biochemiestraße 10,
A-6250 Kundl |
51 % 1993-12-17 |
|
FN 47953 w |
|
|
||||
|
Affiliated companies and
further participations: |
||||
|
HBHG Pharma Ges.m.b.H. |
Mondseestraße 11, A-4866
Unterach Attersee |
|
|
FN 215663 b |
|
Novartis Pharma GmbH |
Stella Klein Löwweg 17,
A-1020 Wien |
|
|
FN 41622 i |
|
EBEWE Spezial-Pharma Holding
GmbH |
Stella Klein Löwweg 17,
A-1020 Wien |
|
|
FN 331193 z |
|
Nabriva Therapeutics AG |
Leberstraße 20, A-1112
Wien |
|
|
FN 269261 y |
|
Novartis Institutes for
BioMedical Research GmbH & Co KG |
Brunnerstraße 59, A-1235
Wien |
2004-10-23 |
|
FN 253505 b |
|
Austrian Center of Biopharmaceutical
Technology |
Muthgasse 18, A-1190
Wien |
|
|
|
Bankers:
|
|
|
|
|
|
Banker |
Bank sort code |
Type of banking connection |
|
|
UniCredit Bank Austria AG,
1011 Wien |
12000 |
main bank connection |
|
|
|
|
||
Historical development:
|
Year of incorporation: |
1965 |
|
Date of registration: |
1965-11-26 |
|
Change of company name: |
||
|
From |
To |
Company name |
|
|
2003-05-02 |
Biochemie GmbH |
|
2003-05-02 |
|
Sandoz GmbH |
|
Change in share capital: |
||
|
From |
To |
Capital |
|
2001-10-05 |
|
EUR 32.703.000,00 |
|
|
2001-10-05 |
ATS 450.000.000,00 |
|
Former executives: |
|||
|
From |
To |
Function |
Name |
|
2002-07-17 |
2007-06-15 |
joint signing clerk |
Dr. Elisabeth Schneider
Scherzer |
|
1998-04-02 |
2007-06-15 |
joint signing clerk |
Dr. Bruno Wallnöfer |
|
2000-01-12 |
2007-06-15 |
joint signing clerk |
Mag. Barbara Weigl Aman |
|
2004-10-06 |
2008-05-29 |
joint signing clerk |
Mag. Elgar Schnegg |
|
2000-05-31 |
2009-02-19 |
joint signing clerk |
Kurt Unterkircher |
|
2000-01-12 |
2010-01-09 |
joint signing clerk |
Dr. Josef Egerbacher |
|
1993-09-23 |
2010-03-19 |
joint signing clerk |
Mag. Friedrich Fuchs |
|
2008-05-29 |
2010-06-18 |
joint signing clerk |
Dipl-Betriebsw. Björn
Komischke |
|
2006-06-23 |
2011-02-10 |
joint signing clerk |
Mag. Helmuth Hofer |
|
2001-12-19 |
2012-05-01 |
joint signing clerk |
Dr. Maria Schmalzl |
|
2010-06-18 |
2012-09-21 |
joint signing clerk |
Dr. Gerhard van der Meij |
|
1998-01-27 |
2012-10-17 |
joint signing clerk |
Dr. Elmar Dolejsi |
|
1993-05-10 |
1997-05-16 |
chairman of the supervisory
board |
Dr. Urs Bärlocher |
|
1997-05-16 |
1998-04-18 |
chairman of the supervisory
board |
Pierre Douaze |
|
1998-04-18 |
1999-10-12 |
chairman of the supervisory
board |
Dr. Argeric Karabelas |
|
1999-10-12 |
2001-10-02 |
chairman of the supervisory
board |
Dipl-Ing.Dr. Oswald Sellemond |
|
2001-10-02 |
2002-05-30 |
chairman of the supervisory
board |
Mag. Christian Seiwald |
|
2002-05-30 |
2005-04-19 |
chairman of the supervisory
board |
Mag. Christian Seiwald |
|
2005-04-19 |
2009-02-19 |
chairman of the supervisory
board |
Dr. Andreas Rummelt |
|
2009-02-19 |
2010-07-29 |
chairman of the supervisory
board |
Dr. Horst Uwe Groh |
|
1999-10-12 |
2000-11-30 |
deputy chairman of the
supervisory board |
Dr. Argeric Karabelas |
|
1997-05-16 |
2002-03-12 |
deputy chairman of the
supervisory board |
Dr. Jörg Reinhardt |
|
2000-11-30 |
2002-05-30 |
deputy chairman of the
supervisory board |
Thomas Ebeling |
|
1995-06-21 |
1997-05-16 |
deputy chairman of the
supervisory board |
Dr. Daniel Vasella |
|
2002-05-30 |
2005-04-19 |
deputy chairman of the
supervisory board |
Paul Choffat |
|
2005-04-19 |
2010-07-29 |
deputy chairman of the supervisory
board |
Mag. Christian Seiwald |
|
2010-07-29 |
2012-09-26 |
deputy chairman of the
supervisory board |
Christina Ackermann Swistara |
|
|
1997-05-16 |
member of the supervisory
board |
Dr. Raymund Breu |
|
|
1998-04-18 |
member of the supervisory
board |
Daniel Wagniere |
|
1998-04-18 |
1999-08-06 |
member of the supervisory
board |
Dr. Hans Kindler |
|
1997-05-16 |
1999-08-06 |
member of the supervisory
board |
Dr. Erwin Schillinger |
|
1999-08-06 |
1999-10-12 |
member of the supervisory
board |
Dipl-Ing.Dr. Oswald Sellemond |
|
1999-08-06 |
2001-10-02 |
member of the supervisory
board |
Mag. Christian Seiwald |
|
2001-10-02 |
2002-05-30 |
member of the supervisory
board |
Dipl-Ing.Dr. Oswald Sellemond |
|
2002-03-12 |
2005-07-14 |
member of the supervisory
board |
Dr. Urs Bärlocher |
|
2005-07-14 |
2007-03-16 |
member of the supervisory
board |
Kevin Plummer |
|
2002-05-30 |
2007-06-28 |
member of the supervisory
board |
Dr. Erwin Schillinger |
|
1999-08-06 |
2008-08-01 |
member of the supervisory
board |
Hermann Egger |
|
2007-06-28 |
2008-08-01 |
member of the supervisory
board |
Dr. Peter Jager |
|
2008-08-01 |
2009-03-11 |
member of the supervisory
board |
Knut Mager |
|
2009-03-11 |
2010-04-20 |
member of the supervisory
board |
Dr. Andreas Rummelt |
|
2010-04-20 |
2010-07-29 |
member of the supervisory
board |
Christina Ackermann Swistara |
|
2010-07-29 |
2010-09-22 |
member of the supervisory
board |
Dr. Horst Uwe Groh |
|
2007-03-16 |
2011-06-30 |
member of the supervisory
board |
Dipl-Ing.Dr. Heinrich
Scherfler |
|
2010-09-22 |
2012-03-09 |
member of the supervisory
board |
Dr. Gerhard Schaefer |
|
|
1998-01-24 |
employee's representative on
the supervisory board |
Johann Auer |
|
|
1999-08-06 |
employee's representative on
the supervisory board |
Helmuth Stubenvoll |
|
2006-06-23 |
2007-06-15 |
joint signing clerk |
Lorraine Lynne Christina Perry |
|
2003-10-01 |
2007-06-15 |
joint signing clerk |
Mag.Dr. Otto Scheidl |
|
1998-10-20 |
1999-04-15 |
joint signing clerk |
Eric Gorka |
|
2001-10-02 |
2003-12-18 |
joint signing clerk |
Dr. Johannes Gerstenbauer |
|
1993-09-23 |
2000-09-13 |
joint signing clerk |
Dr. Otto Streichsbier |
|
1998-01-27 |
2003-12-18 |
joint signing clerk |
Mag. Gottfried Rieser |
|
2003-05-06 |
2004-11-03 |
joint signing clerk |
Mag. Siegfried Johann Leitner |
|
1998-02-02 |
2005-03-08 |
joint signing clerk |
Peter Haselböck |
|
1993-09-23 |
2000-10-11 |
joint signing clerk |
Mag. Hubert Hirzinger |
|
1993-09-23 |
2001-03-13 |
joint signing clerk |
Dr. Eberhard Pirich |
|
1993-09-23 |
2001-10-02 |
joint signing clerk |
Dr. Walter Killiches |
|
1998-01-27 |
2002-04-25 |
joint signing clerk |
Mag. Vinzenz Plörer |
|
1997-11-07 |
2002-10-01 |
joint signing clerk |
Dr. Helmut Deimel |
|
1999-04-15 |
2003-03-19 |
joint signing clerk |
Mag. Gerhard Hörl |
|
1993-09-23 |
2003-04-29 |
joint signing clerk |
Mag. Bernhard Sigl |
|
1993-09-23 |
2005-03-08 |
joint signing clerk |
Dr. Ernst Leitner |
|
1998-01-27 |
2006-05-16 |
joint signing clerk |
Dr. Santiago Alonso Ciriza |
|
2004-08-10 |
2006-05-16 |
joint signing clerk |
Knut Ulrich Mager |
|
2000-03-14 |
2006-05-16 |
joint signing clerk |
Hans Schaller |
|
1993-09-23 |
2007-02-09 |
joint signing clerk |
Mag. Rupert Labner |
|
1999-08-17 |
2003-04-29 |
joint signing clerk |
Mag.Dr. Franz Stumpf |
|
|
1999-04-13 |
manager |
Dipl-Ing.Dr. Oswald Sellemond |
|
|
2003-04-29 |
manager |
Werner Meßner |
|
2003-04-29 |
2004-09-01 |
manager |
Mag.Dr. Franz Stumpf |
|
2003-04-29 |
2005-07-28 |
manager |
Mag. Hubert Hirzinger |
|
2003-04-29 |
2005-07-28 |
manager |
Dr. Patrick Vink |
|
|
2006-06-03 |
manager |
Dipl-Ing.Dr. Heinrich
Scherfler |
|
2004-09-01 |
2007-06-06 |
manager |
Mag. Johannes Schwertner |
|
2003-04-29 |
2008-02-21 |
manager |
Mag. Bernhard Sigl |
|
2008-02-21 |
2010-02-20 |
manager |
Dipl-Ing. Bianca Stöhr |
|
2010-01-09 |
2012-02-03 |
manager |
Mag. Hannes Teißl |
|
2010-11-13 |
2012-12-18 |
manager |
Mag. Richard Kronbichler |
|
1993-09-23 |
1999-02-16 |
joint signing clerk |
Dr. Paul Inama Sternegg |
|
Former shareholders: |
|||
|
From |
To |
Function |
Name |
|
|
1997-02-22 |
partner |
Sandoz Holding AG |
|
1997-02-22 |
2000-08-26 |
partner |
Novartis AG |
|
Former shareholdings: |
||
|
From |
To |
Name |
|
1996-05-08 |
1998-11-24 |
Novartis Handelsgesellschaft
m.b.H. |
|
2004-09-16 |
2004-10-23 |
Novartis Forschungsinstitut
GmbH |
|
2005-01-27 |
2005-10-06 |
Grandis Handel mit
pharmazeutischen Produkten Gesellschaft mbH |
|
2006-01-24 |
2007-11-10 |
Nabriva Therapeutics AG |
|
Mergers: |
||
|
Date |
Function |
Name |
|
2006-12-14 |
merged with |
Sandoz GmbH |
|
2005-10-06 |
merged with |
Grandis Handel mit
pharmazeutischen Produkten Gesellschaft mbH |
|
2000-11-24 |
merged with |
Novartis Handelsgesellschaft
m.b.H. |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.53.85 |
|
|
1 |
Rs.85.25 |
|
Euro |
1 |
Rs.71.72 |
INFORMATION DETAILS
|
Report Prepared
by : |
PDT |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is
calculated from a composite of weighted scores obtained from each of the major
sections of this report. The assessed factors and their relative weights (as
indicated through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.